Section Arrow
TELA.NASDAQ
- TELA Bio
Quotes are at least 15-min delayed:2025/10/23 03:35 EDT
Regular Hours
Last
 1.48
-0.03 (-1.99%)
Day High 
1.51 
Prev. Close
1.51 
1-M High
1.6751 
Volume 
50.99K 
Bid
--
Ask
--
Day Low
1.47 
Open
1.5 
1-M Low
1.4001 
Market Cap 
59.82M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 1.5 
20-SMA 1.5 
50-SMA 1.59 
52-W High 3.26 
52-W Low 0.8645 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.06/-0.39
Enterprise Value
100.94M
Balance Sheet
Book Value Per Share
0.23
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
69.30M
Operating Revenue Per Share
1.24
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
QSIQuantum-Si2.2-0.14-5.98%-- 
BSXBoston Scientific Corp103.85+3.95+3.95%60.57PE
IVFINVO Fertility Inc0.6344+0.0944+17.48%-- 
PACBPacific Biosciences of California1.84-0.06-3.16%-- 
MDTMedtronic plc95.9+0.07+0.07%26.47PE
Quotes are at least 15-min delayed:2025/10/23 03:35 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.